← Back to NRCPortrait, one to two pages. Turn on “background graphics” in the print dialog to keep the table rules.
SPZCONRC HEALTH · NRCData at close 2026-07-30
Health Care · Services-Commercial Physical & Biological Research · Nasdaq · CIK 70487 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
NRC close: $42.9 on 2023-07-31 to $18.9 on 2026-07-30.
Daily closing price, split-adjusted to the current basis; 3y shown of 3,313 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
At a glance
Fair value (model)$8.02
Implied upside−56.2%
Valuation confidenceMEDIUM
Price impliesUNDEMANDING · 14.8% growth
Short interest2.3% of sh out
Days to cover6.2d
13F net flow (QoQ)+0.11%
Top-10 13F concentration68.9%
Next report (est.)2026-10-27
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
Key fundamentalsFY 2025
P/E (FY)35.6×
Sales (TTM)$138.6M
Trailing returns
YTD+2.5%
1Y+54.9%
3Y−51.4%
5Y−59.2%
10Y+49.0%
Since incept. (ann.)+1.6%
Total return through 2026-07-30 · series begins 2013-05-23. Only the windows this history actually covers are shown.
Risk
Ann. volatility (1Y)57.3%
Ann. volatility (3Y)47.1%
Sharpe (1Y)0.98
Sharpe (3Y)−0.28
Max drawdown (1Y)−46.5%
Max drawdown (3Y)−77.6%
Beta (3Y vs SPY)0.43
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
Top institutional holders13F 2026-Q1
Manager
Shares
Value
% sh out
QoQ
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
2.6M
$45M
11.59%
−0.8%
MORGAN STANLEY
1.0M
$17M
4.40%
−0.2%
BlackRock, Inc.
975,855
$17M
4.29%
−2.9%
VANGUARD CAPITAL MANAGEMENT LLC
662,837
$11M
2.91%
new
DIMENSIONAL FUND ADVISORS LP
489,740
$8M
2.15%
−1.0%
GEODE CAPITAL MANAGEMENT, LLC
393,847
$7M
1.73%
+2.7%
QV Investors Inc.
381,310
$6M
1.68%
+0.0%
RENAISSANCE TECHNOLOGIES LLC
340,784
$6M
1.50%
−2.9%
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
Latest reported quarterslast report 2026-04-28
Period end
Reported
EPS
EPS YoY
Revenue
Rev YoY
2026-03-31
2026-04-28
$0.14
−44.0%
$34.8M
+3.7%
2025-12-31
2026-02-03
—
—
$35.2M
−4.6%
2025-09-30
2025-10-27
$0.18
−25.0%
$34.6M
−3.4%
2025-06-30
2025-07-28
−$0.01
−103.8%
$34.0M
−2.8%
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-27 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Basis & disclosures
End-of-day only. Every price on this sheet is a stored CLOSE — the last one is 2026-07-30. Nothing here is live, intraday or delayed-real-time, and the sheet does not update after it is printed.
Nothing is imputed. A figure that is not in the underlying filing or feed renders as “—”. We never fill a gap with an estimate, a peer median or a carried-forward value.
Mixed as-of dates by design. Prices are at the last close; fundamentals are at the latest reported fiscal period; 13F ownership is at the latest filed quarter (45+ days in arrears); short interest is the latest FINRA settlement. Each block states its own basis above.
Not investment advice. Model fair values, reverse-DCF grades and confidence labels are the output of published, disclosed methods on public filings — they are analysis, not a recommendation, a price target or a solicitation.
Fundamentals and ownership derive from SEC EDGAR (and equivalent foreign registers); prices from a licensed end-of-day vendor, shown under a neutral source label. Full methodology at spzco.com/methodology.
Earnings (TTM)$9.0M
ROE51.2%
Net margin8.4%
ROIC17.3%
Debt / equity5.36×
Total debt / EBITDA2.48×
EPS growth 3Y240.2%
Sales growth 3Y−3.2%
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
